2021
DOI: 10.3389/fcimb.2021.673503
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae in a Tertiary Care Teaching Hospital

Abstract: BackgroundOver the last two decades, the prevalence of colistin resistance among the members of Enterobacteriaceae has been increasing, particularly among Klebsiella pneumoniae isolates; this limits the potential use of colistin and leads to worsened clinical outcomes.MethodsWe investigated the prevalence and genetic characteristics of colistin-resistant K. pneumoniae (COLR-KP) in clinical isolates using genomic sequencing.ResultsIn total, 53 K. pneumoniae isolates (4.5%, 53/1,171) were confirmed as COLR-KP, o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 41 publications
5
15
0
Order By: Relevance
“…The global spread of ESBL-producing bacteria, especially ESBL-positive E. coli and K. pneumoniae , poses a challenge to treating MDR bacteria ( Chong et al, 2018 ). The resistance of bacteria to colistin in peptide drugs has gradually gained attention as a result of greater attention to carbapenem-resistant K. pneumoniae ( CRKP ), and the emergence of the Mobile Colistin Resistance ( mcr ) gene poses no small threat to global public health ( Wang et al., 2017a ; Liu et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The global spread of ESBL-producing bacteria, especially ESBL-positive E. coli and K. pneumoniae , poses a challenge to treating MDR bacteria ( Chong et al, 2018 ). The resistance of bacteria to colistin in peptide drugs has gradually gained attention as a result of greater attention to carbapenem-resistant K. pneumoniae ( CRKP ), and the emergence of the Mobile Colistin Resistance ( mcr ) gene poses no small threat to global public health ( Wang et al., 2017a ; Liu et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The lowest resistance rates were observed against colistin and tigecycline, agreeing with a prior study from Brazil ( Vivan et al, 2017 ). However, emerging colistin resistance has been reported from China ( Liu et al, 2021 ). An extensive spectrum of drug resistance has been observed in OmpK35- and OmpK36-deficient K. pneumoniae , in association with ESBL and AmpC production, leading to the development of substantial resistance against the β-lactam antibiotics, fluoroquinolone, and aminoglycosides ( Hamzaoui et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, treatment options for XDR-KP mainly rely on the last-resort antibiotics colistin and tigecycline. However, K. pneumoniae may develop a succession of resistance-associated determinants, including related chromosomal-located mutations or acquired plasmid-mediated resistance genes ( Liu et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The underlying mechanisms contributing to colistin resistance in XDR-KP are usually mediated by chromosomal mutations ( mgrB , phoP / phoQ , pmrA / pmrB and crrAB ) as well as plasmid-related mcr-1 and its variants ( mcr-2 to mcr-10 ) ( Liu et al., 2016 ; Jayol et al., 2017 ; Poirel et al., 2017 ; Wang et al., 2018 ). Nonetheless, the co-existence of mcr-1 and mcr-8 in XDR-KP is relatively rare ( Liu et al., 2021 ).…”
Section: Introductionmentioning
confidence: 99%